Correlation Between Iovance Biotherapeutics and Sana Biotechnology
Can any of the company-specific risk be diversified away by investing in both Iovance Biotherapeutics and Sana Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iovance Biotherapeutics and Sana Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iovance Biotherapeutics and Sana Biotechnology, you can compare the effects of market volatilities on Iovance Biotherapeutics and Sana Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iovance Biotherapeutics with a short position of Sana Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iovance Biotherapeutics and Sana Biotechnology.
Diversification Opportunities for Iovance Biotherapeutics and Sana Biotechnology
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Iovance and Sana is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Iovance Biotherapeutics and Sana Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sana Biotechnology and Iovance Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iovance Biotherapeutics are associated (or correlated) with Sana Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sana Biotechnology has no effect on the direction of Iovance Biotherapeutics i.e., Iovance Biotherapeutics and Sana Biotechnology go up and down completely randomly.
Pair Corralation between Iovance Biotherapeutics and Sana Biotechnology
Given the investment horizon of 90 days Iovance Biotherapeutics is expected to generate 0.93 times more return on investment than Sana Biotechnology. However, Iovance Biotherapeutics is 1.07 times less risky than Sana Biotechnology. It trades about 0.05 of its potential returns per unit of risk. Sana Biotechnology is currently generating about -0.02 per unit of risk. If you would invest 549.00 in Iovance Biotherapeutics on September 14, 2024 and sell it today you would earn a total of 227.00 from holding Iovance Biotherapeutics or generate 41.35% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Iovance Biotherapeutics vs. Sana Biotechnology
Performance |
| Timeline |
| Iovance Biotherapeutics |
| Sana Biotechnology |
Iovance Biotherapeutics and Sana Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Iovance Biotherapeutics and Sana Biotechnology
The main advantage of trading using opposite Iovance Biotherapeutics and Sana Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iovance Biotherapeutics position performs unexpectedly, Sana Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sana Biotechnology will offset losses from the drop in Sana Biotechnology's long position.| Iovance Biotherapeutics vs. PTC Therapeutics | Iovance Biotherapeutics vs. Krystal Biotech | Iovance Biotherapeutics vs. Sarepta Therapeutics | Iovance Biotherapeutics vs. Madrigal Pharmaceuticals |
| Sana Biotechnology vs. Puma Biotechnology | Sana Biotechnology vs. Iovance Biotherapeutics | Sana Biotechnology vs. Day One Biopharmaceuticals | Sana Biotechnology vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |